Clozapine
 
German Version French Version
 

Clozapine 8-Chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
C18H19ClN4, M = 326,82 g/mol

Antipsychotic (atypical neuroleptic)

Brand Names: Clozaril®, Leponex®. Tablets with 25, 50 or 100 mg clozapine.

Application

Treatment of acute or chronic schizophrenia, especially in treatment-restistant cases. Beginning with a dose of 12,5 mg, slowly increased to 200 up to 450 mg/day but not over a maximum of 600 mg/day. Half life 6 to 25 hours. Clozapine was already synthetisized in 1960 and available from 1971. It is the only atypical neuroleptic without appearance of extrapyramidal-motoric disorders.

Contraindications

Do not use in cases of blood disturbances, especially leucozytic disorders. High risk of agranulozytosis in the first 18 weeks of consumption.

Adverse effects

Sedation, tremors, obstipation, weight gain.

Analytics

Therapeutic blood level 0,03 to 0,06 µg/ml

Overview antipsychotics

Custom Search

 

 

 

Last modification (M-D-Y): 02/08/2019 - IMPRINT - FAQ